Jaguar Animal Health, Inc. (JAGX) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 71 transactions totaling $1.5M, demonstrating a bullish sentiment with $315.3K in net insider flow. The most recent transaction on Dec 11, 2025 involved a transaction of 11,740 shares valued at $0.
No significant insider buying has been recorded for JAGX in the recent period.
No significant insider selling has been recorded for JAGX in the recent period.
Based on recent SEC filings, insider sentiment for JAGX is bullish with an Insider Alignment Score of 60/100 and a net flow of $315.3K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Jaguar Animal Health, Inc. (JAGX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading JAGX stock, having executed 71 transactions in the past 90 days. The most active insider is James J. Bochnowski (Executive), who has made 12 transactions totaling $1.3M.
Get notified when executives and directors at JAGX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | R. Lizak Carol | Executive | Award | 11,740 | $N/A | $0 | |
| Dec 11, 2025 | Jayasuriya Anula | Executive | Award | 5,870 | $N/A | $0 | |
| Dec 11, 2025 | B. Siegel Jonathan | Executive | Award | 7,377 | $N/A | $0 | |
| Dec 11, 2025 | J. Bochnowski James | Executive | Award | 6,363 | $N/A | $0 | |
| Dec 11, 2025 | R. Chaturvedi Pravin | Executive | Award | 11,740 | $N/A | $0 | |
| May 17, 2024 | A. Conte Lisa | Executive | Option Exercise | 2,695 | $N/A | $0 | |
| May 17, 2024 | R. King Steven | Executive | Option Exercise | 612 | $N/A | $0 | |
| May 17, 2024 | R. Lizak Carol | Executive | Option Exercise | 431 | $N/A | $0 | |
| May 17, 2024 | S. Wolin Jonathan | Executive | Option Exercise | 871 | $N/A | $0 | |
| May 17, 2024 | R. Chaturvedi Pravin | Executive | Option Exercise | 871 | $N/A | $0 | |
| Apr 5, 2024 | A. Conte Lisa | Executive | Option Exercise | 600 | $N/A | $0 | |
| Apr 5, 2024 | R. King Steven | Executive | Option Exercise | 178 | $N/A | $0 | |
| Apr 5, 2024 | R. Lizak Carol | Executive | Option Exercise | 60 | $N/A | $0 | |
| Apr 5, 2024 | S. Wolin Jonathan | Executive | Option Exercise | 89 | $N/A | $0 | |
| Apr 5, 2024 | R. Chaturvedi Pravin | Executive | Option Exercise | 134 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 13 | $911.9K | 46.6% |
Sale(S) | 3 | $596.7K | 30.5% |
Conversion(C) | 5 | $450.0K | 23.0% |
Award(A) | 15 | $0 | 0.0% |
Exercise(M) | 34 | $0 | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Insider activity at Jaguar Animal Health, Inc. shows mixed signals across all time. While $911.9K in purchases indicates some executive confidence,$596.7K in sales balances the picture, resulting in a modest net flow of $315.3K.14 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, James J. Bochnowski, has transacted $1.3M during this period.